Overview


"Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (IRIS 2)."

Pixium Vision has developed IRIS® to demonstrate that the Epi-retinal implant will provide patients with improved perception, thus offering more autonomy and a better quality of life.

The IRIS® system currently in clinical trial has been designed so that RP patients can “perceive” objects by recognising their size, position, orientation and movement.

The objective of this advanced epi-retinal Bionic Vision Restoration System (VRS) is to enable patients to identify and pick up a cup, shake hands and recognise certain objects such as a plate, a table, a door or a chair.

ClinicalTrials.gov : https://www.clinicaltrials.gov/ct2/show/NCT02670980?term=Pixium&rank=1

Enrollment of this clinical trial has been closed. Please visit our website frequently to be informed about new clinical trials.